424 related articles for article (PubMed ID: 32088213)
1. Electroacupuncture preconditioning attenuates acute myocardial ischemia injury through inhibiting NLRP3 inflammasome activation in mice.
Zhang T; Yang WX; Wang YL; Yuan J; Qian Y; Sun QM; Yu ML; Fu SP; Xu B; Lu SF
Life Sci; 2020 May; 248():117451. PubMed ID: 32088213
[TBL] [Abstract][Full Text] [Related]
2. [Effects of electroacupuncture pretreatment on cardiac function and immune inflammatory response in mice with acute myocardial ischemia].
Zhang T; Chen Y; Li RH; Wang YL; Fu SP; Yang Y; Xu B; Lu SF
Zhongguo Zhen Jiu; 2020 Jun; 40(6):635-9. PubMed ID: 32538016
[TBL] [Abstract][Full Text] [Related]
3. [Effect of different electrical current intensities of electroacupuncture preconditioning on cardiac function and macrophage polarization in mice with acute myocardial ischemia].
Yang WX; Chen LY; Yang JL; Shi JJ; Ma NQ; Peng YJ; Lu SF
Zhen Ci Yan Jiu; 2022 Nov; 47(11):955-61. PubMed ID: 36453671
[TBL] [Abstract][Full Text] [Related]
4. IL-17A contributes to myocardial ischemic injury by activating NLRP3 inflammasome in macrophages through AMPKα/p38MAPK/ERK1/2 signal pathway in mice.
Zhang L; Liu P; Wen W; Bai X; Zhang Y; Liu M; Wang L; Wu Y; Yuan Z; Zhou J
Mol Immunol; 2019 Jan; 105():240-250. PubMed ID: 30562644
[TBL] [Abstract][Full Text] [Related]
5. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-495 Ameliorates Cardiac Microvascular Endothelial Cell Injury and Inflammatory Reaction by Suppressing the NLRP3 Inflammasome Signaling Pathway.
Zhou T; Xiang DK; Li SN; Yang LH; Gao LF; Feng C
Cell Physiol Biochem; 2018; 49(2):798-815. PubMed ID: 30165354
[TBL] [Abstract][Full Text] [Related]
7. Calcium-Sensing Receptor on Neutrophil Promotes Myocardial Apoptosis and Fibrosis After Acute Myocardial Infarction via NLRP3 Inflammasome Activation.
Ren Z; Yang K; Zhao M; Liu W; Zhang X; Chi J; Shi Z; Zhang X; Fu Y; Liu Y; Yin X
Can J Cardiol; 2020 Jun; 36(6):893-905. PubMed ID: 32224080
[TBL] [Abstract][Full Text] [Related]
8. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 inflammasome activation in murine macrophages caused by Neospora caninum infection.
Wang X; Gong P; Zhang X; Wang J; Tai L; Wang X; Wei Z; Yang Y; Yang Z; Li J; Zhang X
Parasit Vectors; 2017 May; 10(1):266. PubMed ID: 28558839
[TBL] [Abstract][Full Text] [Related]
10. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
[TBL] [Abstract][Full Text] [Related]
11. Mechanism and Regulation of NLRP3 Inflammasome Activation.
He Y; Hara H; Núñez G
Trends Biochem Sci; 2016 Dec; 41(12):1012-1021. PubMed ID: 27669650
[TBL] [Abstract][Full Text] [Related]
12. Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation.
Zhang J; Wang C; Wang H; Li X; Xu J; Yu K
Int Immunopharmacol; 2021 Jun; 95():107529. PubMed ID: 33744777
[TBL] [Abstract][Full Text] [Related]
13. Dectin-2 is a primary receptor for NLRP3 inflammasome activation in dendritic cell response to Histoplasma capsulatum.
Chang TH; Huang JH; Lin HC; Chen WY; Lee YH; Hsu LC; Netea MG; Ting JP; Wu-Hsieh BA
PLoS Pathog; 2017 Jul; 13(7):e1006485. PubMed ID: 28671985
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 Inflammasome and Caspase-1/11 Pathway Orchestrate Different Outcomes in the Host Protection Against
Paroli AF; Gonzalez PV; Díaz-Luján C; Onofrio LI; Arocena A; Cano RC; Carrera-Silva EA; Gea S
Front Immunol; 2018; 9():913. PubMed ID: 29774028
[TBL] [Abstract][Full Text] [Related]
15. Metformin protects against ischaemic myocardial injury by alleviating autophagy-ROS-NLRP3-mediated inflammatory response in macrophages.
Fei Q; Ma H; Zou J; Wang W; Zhu L; Deng H; Meng M; Tan S; Zhang H; Xiao X; Wang N; Wang K
J Mol Cell Cardiol; 2020 Aug; 145():1-13. PubMed ID: 32470468
[TBL] [Abstract][Full Text] [Related]
16. NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation.
Li H; Zhang S; Li F; Qin L
Mol Immunol; 2016 Aug; 76():90-7. PubMed ID: 27393910
[TBL] [Abstract][Full Text] [Related]
17. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
19. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
[TBL] [Abstract][Full Text] [Related]
20. Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production.
Hu Y; Mao K; Zeng Y; Chen S; Tao Z; Yang C; Sun S; Wu X; Meng G; Sun B
J Immunol; 2010 Dec; 185(12):7699-705. PubMed ID: 21048113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
